Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

Abstract

MULTIPLE endocrine neoplasia type 2 (MEN 2) comprises three clinically distinct, dominantly inherited cancer syndromes. MEN 2A patients develop medullary thyroid carcinoma (MTC) and phaeochromocytoma. MEN 2B patients show in addition ganglioneuromas of the gastrointestinal tract and skeletal abnormalities. In familial MTC, only the thyroid is affected. Germ-line mutations of the RET proto-oncogene have recently been reported in association with MEN 2A and familial MTC1,2. All mutations occurred within codons specifying cysteine residues in the transition point between the RETprotein extracellular and transmem-brane domains. We now show that MEN 2B is also associated with mutation of the RET proto-oncogene. A mutation in codon 664, causing the substitution of a threonine for a methionine in the tyrosine kinase domain of the protein, was found in all nine unrelated MEN 2B patients studied. The same mutation was found in six out of 18 sporadic tumours.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Mulligan, L. M. et al. Nature 363, 458–460 (1993).

    Article  ADS  CAS  Google Scholar 

  2. Donis-Keller, H. et al. Hum. molec. Genet. 2, 851–856 (1993).

    Article  CAS  Google Scholar 

  3. Jackson, C. E., Block, M. A., Greenawald, K. A. & Tashjian, A. H. Am. J. hum. Genet. 101, 704–710 (1979).

    Google Scholar 

  4. Mathew, C. G. P. et al. Nature 328, 527–528 (1987).

    Article  ADS  CAS  Google Scholar 

  5. Simpson, N. E. et al. Nature 328, 528–530 (1987).

    Article  ADS  CAS  Google Scholar 

  6. Norum, R. A. et al. Genomics 8, 313–317 (1990).

    Article  CAS  Google Scholar 

  7. Landsvater, R. M. et al. Genomics 4, 246–250 (1989).

    Article  CAS  Google Scholar 

  8. Nelkin, B. D. et al. Cancer Res. 49, 4114–4119 (1989).

    CAS  Google Scholar 

  9. Ceccherini, I. et al. Biochem. biophys. Res. Commun. 196, 1288–1295 (1993).

    Article  CAS  Google Scholar 

  10. Takahashi, M. et al. Oncogene 3, 571–578 (1988).

    CAS  Google Scholar 

  11. Hanks, S. K., Quinn, A. M. & Hunter, T. Science 241, 42–52 (1988).

    Article  ADS  CAS  Google Scholar 

  12. Schneider, R. Trends biochem. Sci. 17, 468–469 (1992).

    Article  CAS  Google Scholar 

  13. Schuchardt, A., Agati, V. D., Costantini, G. & Pachnis, V. Abstr. Cold Spring Harbor Meeting on Mouse Molecular Genetics 1992.

  14. Orita, M., Suzuki, Y., Sekiya, T. & Hayashi, K. Genomics 5, 873–879 (1989).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hofstra, R., Landsvater, R., Ceccherini, I. et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367, 375–376 (1994). https://doi.org/10.1038/367375a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/367375a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing